171 related articles for article (PubMed ID: 23879635)
21. Pharmacological inhibition of lipid droplet formation enhances the effectiveness of curcumin in glioblastoma.
Zhang I; Cui Y; Amiri A; Ding Y; Campbell RE; Maysinger D
Eur J Pharm Biopharm; 2016 Mar; 100():66-76. PubMed ID: 26763536
[TBL] [Abstract][Full Text] [Related]
22. In vitro cytotoxicity and cellular uptake of curcumin-loaded Pluronic/Polycaprolactone micelles in colorectal adenocarcinoma cells.
Raveendran R; Bhuvaneshwar G; Sharma CP
J Biomater Appl; 2013 Mar; 27(7):811-27. PubMed ID: 22274881
[TBL] [Abstract][Full Text] [Related]
23. Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles.
Chuah LH; Roberts CJ; Billa N; Abdullah S; Rosli R
Colloids Surf B Biointerfaces; 2014 Apr; 116():228-36. PubMed ID: 24486834
[TBL] [Abstract][Full Text] [Related]
24. Curcumin suppressed anti-apoptotic signals and activated cysteine proteases for apoptosis in human malignant glioblastoma U87MG cells.
Karmakar S; Banik NL; Ray SK
Neurochem Res; 2007 Dec; 32(12):2103-13. PubMed ID: 17562168
[TBL] [Abstract][Full Text] [Related]
25. Effect of high-pressure homogenization and stabilizers on the physicochemical properties of curcumin-loaded glycerol monooleate/chitosan nanostructures.
Mistry PH; Mohapatra SK; Dash AK
Nanomedicine (Lond); 2012 Dec; 7(12):1863-76. PubMed ID: 22709346
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic potentials of curcumin in the treatment of glioblstoma.
Shabaninejad Z; Pourhanifeh MH; Movahedpour A; Mottaghi R; Nickdasti A; Mortezapour E; Shafiee A; Hajighadimi S; Moradizarmehri S; Sadeghian M; Mousavi SM; Mirzaei H
Eur J Med Chem; 2020 Feb; 188():112040. PubMed ID: 31927312
[TBL] [Abstract][Full Text] [Related]
27. Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy.
Mohanty C; Acharya S; Mohanty AK; Dilnawaz F; Sahoo SK
Nanomedicine (Lond); 2010 Apr; 5(3):433-49. PubMed ID: 20394536
[TBL] [Abstract][Full Text] [Related]
28. Nano-structures mediated co-delivery of therapeutic agents for glioblastoma treatment: A review.
Mujokoro B; Adabi M; Sadroddiny E; Adabi M; Khosravani M
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():1092-102. PubMed ID: 27612807
[TBL] [Abstract][Full Text] [Related]
29. Curcumin-loaded polymeric nanoparticles for enhanced anti-colorectal cancer applications.
Udompornmongkol P; Chiang BH
J Biomater Appl; 2015 Nov; 30(5):537-46. PubMed ID: 26170212
[TBL] [Abstract][Full Text] [Related]
30. Y-shaped Folic Acid-Conjugated PEG-PCL Copolymeric Micelles for Delivery of Curcumin.
Feng R; Zhu W; Chu W; Teng F; Meng N; Deng P; Song Z
Anticancer Agents Med Chem; 2017; 17(4):599-607. PubMed ID: 27528180
[TBL] [Abstract][Full Text] [Related]
31. The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals.
Wang Y; Ying X; Xu H; Yan H; Li X; Tang H
Int J Nanomedicine; 2017; 12():1369-1384. PubMed ID: 28260885
[TBL] [Abstract][Full Text] [Related]
32. Sequential delivery of dual drugs with nanostructured lipid carriers for improving synergistic tumor treatment effect.
Xu M; Li G; Zhang H; Chen X; Li Y; Yao Q; Xie M
Drug Deliv; 2020 Dec; 27(1):983-995. PubMed ID: 32611218
[TBL] [Abstract][Full Text] [Related]
33. Flower-like curcumin-loaded folic acid-conjugated ZnO-MPA- βcyclodextrin nanostructures enhanced anticancer activity and cellular uptake of curcumin in breast cancer cells.
Ghaffari SB; Sarrafzadeh MH; Fakhroueian Z; Khorramizadeh MR
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109827. PubMed ID: 31349522
[TBL] [Abstract][Full Text] [Related]
34. Modulation of Biological Activities in Glioblastoma Mediated by Curcumin.
Trotta T; Panaro MA; Prifti E; Porro C
Nutr Cancer; 2019; 71(8):1241-1253. PubMed ID: 31007066
[TBL] [Abstract][Full Text] [Related]
35. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors.
Lim KJ; Bisht S; Bar EE; Maitra A; Eberhart CG
Cancer Biol Ther; 2011 Mar; 11(5):464-73. PubMed ID: 21193839
[TBL] [Abstract][Full Text] [Related]
36. Curcumin changes the polarity of tumor-associated microglia and eliminates glioblastoma.
Mukherjee S; Baidoo J; Fried A; Atwi D; Dolai S; Boockvar J; Symons M; Ruggieri R; Raja K; Banerjee P
Int J Cancer; 2016 Dec; 139(12):2838-2849. PubMed ID: 27543754
[TBL] [Abstract][Full Text] [Related]
37. Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt/mTOR Pathway in Cultured Glioblastoma Cells.
Maiti P; Scott J; Sengupta D; Al-Gharaibeh A; Dunbar GL
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669284
[TBL] [Abstract][Full Text] [Related]
38. The anti-cancer efficacy of curcumin scrutinized through core signaling pathways in glioblastoma.
Su CC; Wang MJ; Chiu TL
Int J Mol Med; 2010 Aug; 26(2):217-24. PubMed ID: 20596601
[TBL] [Abstract][Full Text] [Related]
39. Micelle-assisted combination therapies for effective glioblastoma treatment: an in-vitro assessment.
Mohanty AK; Mohanta GP
Anticancer Drugs; 2015 Mar; 26(3):312-22. PubMed ID: 25462134
[TBL] [Abstract][Full Text] [Related]
40. Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models.
Sarisozen C; Dhokai S; Tsikudo EG; Luther E; Rachman IM; Torchilin VP
Eur J Pharm Biopharm; 2016 Nov; 108():54-67. PubMed ID: 27569031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
